Concurrent Session

Concurrent Group I

The concurrent sessions cover topics from across the spectrum of stem cell research. Each session, framed by a brief topic overview, includes one or two invited speakers whose work highlights leading research in the field. The session is rounded out with four or more abstract-selected speakers who, combined with the invited talks, give an excellent snapshot of the most current work on the topic. The five concurrent sessions run in parallel and attendees are encouraged to move between sessions to hear talks of interest. Concurrent sessions are held Thursday, Friday, and Saturday afternoons.

Concurrent IC: Cardiac Development and Disease

13:15 - 15:15


Charles E. Murry

University of Washington, WA, United States

Dr. Charles (Chuck) Murry received his MD-PhD at Duke University, studying myocardial ischemia-reperfusion injury. He did residency training in Pathology at the University of Washington, followed by fellowships in vascular biology and diagnostic cardiovascular pathology. He is currently a professor of Pathology, Bioengineering, and Medicine/Cardiology at the UW. Dr. Murry’s research focuses on stem cell biology, emphasizing differentiation of the human cardiovascular system and using these cells to study diseases and to regenerate damaged tissues. His group is a world leader in heart regeneration and is working toward a clinical trial using cardiomyocyte therapy. Murry is Director of the UW Institute for Stem Cell and Regenerative Medicine, Director of the UW Medicine Heart Regeneration Program, and Co-Director of the UW Center for Cardiovascular Biology.


Send Email for Charles Murry

Christine L. Mummery

Leiden University Medical Center, Netherlands

Christine Mummery is Chair of the Department of Anatomy and Embryology and Professor of Developmental Biology at Leiden University Medical Center. Mummery’s research focuses on heart development and uses human pluripotent stem cells to develop disease models to understand the underlying causes and progression of heart disease and develop drugs for treatment. Mummery was editor-in-chief of the ISSCR journal, Stem Cell Reports, from its inception in 2013 through 2018. She is a member of the Royal Netherlands Academy of Science, and former board member of the Netherlands Medical Research Council. She has been awarded a number of prizes, including several for research on animal alternatives.


Send Email for Christine Mummery

Milena Bellin


Send Email for Milena Bellin

Elisa Giacomelli



Send Email for Elisa Giacomelli

Berend van Meer


Send Email for Berend van Meer

Valeria Orlova


Send Email for Valeria Orlova

Luca Sala


Send Email for Luca Sala

Leon Tertoolen


Send Email for Leon Tertoolen

Takafumi Toyohara

Beth Israel Deaconess Medical Center, MA, United States


Send Email for Takafumi Toyohara

Kai Kretzschmar

Hubrecht Institute, Netherlands


Send Email for Kai Kretzschmar

Nadia A. Rosenthal

The Jackson Laboratory, ME, United States


Send Email for Nadia Rosenthal

Nathan Palpant

The University of Queensland, QLD, Australia


Send Email for Nathan Palpant

Deepak Srivastava

Gladstone Institutes, CA, United States

Deepak Srivastava, M.D., is President of the Gladstone Institutes, Director of the Roddenberry Stem Cell Center at Gladstone, and Professor at the University of California, San Francisco. Dr. Srivastava’s laboratory discovered genetic bases for human cardiac septal and valve defects and revealed complex gene networks that regulate progenitor cells to adopt a cardiac cell fate and subsequently fashion a functioning heart. He has leveraged this knowledge to reprogram fibroblasts directly into cardiomyocyte-like cells.


Send Email for Deepak Srivastava


Concurrent IC: Cardiac Development and Disease

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Concurrent IC: Cardiac Development and Disease